A 7387
Alternative Names: A-7387Latest Information Update: 15 Jan 2024
At a glance
- Originator Albireo Pharma
- Class Antivirals
- Mechanism of Action Sodium-bile acid cotransporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cholestasis; Hepatitis B; Hepatitis D